Conmed Corp revenue
Conmed Corp's revenue was $1.37bn in fiscal 2025, up 5.2% on the year before. Since fiscal 2009 ($695m) it has grown at a compound 4.4% a year.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 695 | 714 | 725 | 767 | 763 | 740 | 719 | 764 | 796 | 860 | 955 | 862 | 1,011 | 1,045 | 1,245 | 1,307 | 1,375 |
| Growth on the year before | — | +2.7% | +1.6% | +5.8% | −0.6% | −3.0% | −2.8% | +6.2% | +4.3% | +7.9% | +11.1% | −9.7% | +17.2% | +3.4% | +19.1% | +5.0% | +5.2% |
| Gross profit | 337 | 365 | 375 | 406 | 412 | 404 | 382 | 408 | 431 | 469 | 525 | 460 | 568 | 571 | 676 | 733 | 750 |
| Gross margin | 48.6% | 51.2% | 51.7% | 52.9% | 54.1% | 54.6% | 53.1% | 53.5% | 54.1% | 54.6% | 54.9% | 53.4% | 56.2% | 54.6% | 54.3% | 56.1% | 54.6% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| General Surgery | $800M | 58.2% | ▲ 4.9% |
| Orthopedic Surgery | $575M | 41.8% | ▲ 5.6% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $775M | 56.3% | ▲ 3.5% |
| EMEA | $265M | 19.3% | ▲ 8.9% |
| Asia Pacific | $209M | 15.2% | ▲ 7.2% |
| Americasexcludingthe United States | $127M | 9.2% | ▲ 4.7% |
From Conmed Corp's 10-K filed February 17, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Conmed Corp | $1.37bn | 5.2% | 9.6% |
| Haemonetics Corp | $1.35bn | 0.4% | 3.5% |
| Stevanato Group S.p.a. | $1.34bn | 12.3% | — |
| Penumbra Inc | $1.56bn | 17.0% | 16.2% |
| Merit Medical Systems Inc | $1.61bn | 9.1% | 9.5% |
| Integra Lifesciences Holdings Corp | $1.66bn | 0.8% | 2.4% |
Compare with peers
- Haemonetics Corp revenue
- Stevanato Group S.p.a. revenue
- Penumbra Inc revenue
- Merit Medical Systems Inc revenue
- Integra Lifesciences Holdings Corp revenue
Head to head: CNMD vs HAECNMD vs STVNCNMD vs PEN
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies